[HTML][HTML] ACV y covid-19: una revisión de los estudios observacionales publicados en época de pandemia

M Ortiz, N Valencia, E Moreno, M Zafra… - Acta Neurológica …, 2020 - scielo.org.co
RESUMEN INTRODUCCIÓN: En marzo 2020 la Organización Mundial de la Salud decretó
la pandemia por covid-19. Se han informado casos de ACV relacionados con esta infección …

[HTML][HTML] The issue of the antiphospholipid antibody syndrome

DC Oliveira, A Correia, C Oliveira - Journal of clinical medicine …, 2020 - ncbi.nlm.nih.gov
Antiphospholipid antibody syndrome (APS) is a state of hypercoagulability secondary to an
autoimmune disorder. It is associated with thrombotic events in venous and arterial vessels …

Determination of thrombogenicity levels of various antiphospholipid antibodies by a modified thrombin generation assay in patients with suspected antiphospholipid …

P Bradáčová, L Slavík, A Skoumalová… - International Journal of …, 2022 - mdpi.com
Antiphospholipid syndrome (APS) is a hypercoagulable state accompanied by the presence
of heterogeneous antiphospholipid antibodies (aPL), which nonspecifically affect …

Antiphospholipid Antibody Testing: An Audit on Testing Practices in a Public Tertiary Care Center

EM Mansory, HM Alahwal, SM Bahashwan… - Journal of Clinical …, 2023 - mdpi.com
Background: Antiphospholipid antibodies (aPLs) are antibodies directed against cell
membrane components and can be associated with clinical features or be asymptomatic …

Is there any relationship between massive ascites and elevated CA-125 in systemic lupus erythematosus? Case report and review of the literature

E Quintero-Muñoz, MA Gómez Pineda… - Modern …, 2021 - academic.oup.com
Systemic lupus erythematosus (SLE) is a chronic, multisystemic autoimmune disease of
variable presentation. Massive ascites in the context of SLE is infrequent. Even so, it has …

Predictors and Interrelationship of Patient‐Reported Outcomes in Antiphospholipid Syndrome: A Cross‐Sectional Study

JK Weiner, T Smith, CK Hoy, C Sarosh… - ACR Open …, 2023 - Wiley Online Library
Objective This study assessed patient‐reported outcomes (PROs) in individuals with
persistently positive antiphospholipid antibodies (aPL) to better understand how living with …

Left ventricular longitudinal global strain to predict severe coronary disease in patients with precordial pain suggestive of non-ST-segment elevation acute coronary …

MA Tibaldi, C Ruiz, ML Servato… - Journal of …, 2020 - journals.lww.com
Background: Diagnosing non-ST-segment elevation acute coronary syndrome (NSTE-ACS)
is not always straightforward. Left ventricular global longitudinal strain (LVGLS) is an …

Left ventricular thrombus: an interesting presentation of primary antiphospholipid antibody syndrome with a mini-review of the literature

GR Kiran, J Shashivardhan… - Journal of …, 2020 - journals.lww.com
Antiphospholipid syndrome (APLS) is characterized by recurrent thrombosis. We report the
case of a 36-year-old male who had acute right-sided ischemic stroke and right leg ischemia …

Antiphospholipid syndrome: a case report with an unusual wide spectrum of clinical manifestations

C Mazzoccoli, D Comitangelo, A D'Introno… - Autoimmunity …, 2019 - Springer
Background Antiphospholipid syndrome (APS) is an autoimmune disease characterized by
the occurrence of venous and/or arterial thrombosis, and the detection of circulating …

[HTML][HTML] Antiphosphatidylserine antibody as a cause of multiple dural venous sinus thromboses and ST-elevation myocardial infarction

CK Varner, CW Marquardt… - The American Journal of …, 2018 - ncbi.nlm.nih.gov
Objective: Rare disease Background: Antiphospholipid syndrome (APS) is an autoimmune
disease characterized by antibodies directed against phospholipids on plasma membranes …